Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Join | Sign in
Home>Products>Product News
  Service News
BIOTRONIK Releases Line-Extension of Orsiro Hybrid Drug Eluting Stent
Tuesday, September 03, 2013
The highly deliverable Orsiro stent is now available in lengths up to 40 mm to address a wider range of lesions.

OCT are Expanding the Use of the CTMS Platform with Flex Databases
Thursday, August 29, 2013
Expansion to implement the workflow management tool.

Bio Farma Launches Pentavalent Vaccine, Combining Five Antigens
Tuesday, August 27, 2013
One shot of the vaccine will prevent babies from five diseases at once.

CluePoints Cited in New FDA Guidance for Improved Data Quality
Wednesday, August 14, 2013
CSM techniques have been cited by the FDA in the recent release of the final guidance document detailing the agency's stance on the "Oversight of Clinical Investigations".

Apeiron and Rentschler Announces Partnership Agreement
Friday, August 02, 2013
Rentschler produces Apeiron's monoclonal antibody APN311 for late stage clinical development and market.

Thermo Fisher Scientific Showcases New Small Benchtop Centrifuge at AACC
Thursday, August 01, 2013
Provides scientists with outstanding capacity in a compact design.

Intelsius Introduces Reusable Courier Transit Case
Monday, July 29, 2013
BioCarrier™ - Designed for local courier routes and multiple site sample collections.

BASF, Cargill and Novozymes Achieve Milestone in Bio-Based Acrylic Acid Process
Thursday, July 11, 2013
Success in producing 3-hydroxypropionic acid for bio-based acrylic acid.

Ask the Expert: Strategies to Maximize Return on Idle Equipment
Monday, June 24, 2013
Roger Gallo answers some frequently asked questions about how to achieve a good return on equipment.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 298
Scientific News
Ebola Test Vaccines Appear Safe in Phase 2 Liberian Clinical Trial
Liberia-U.S. partnership planning Phase 3 trial and study of Ebola survivors.
NIH Works to Improve Kidney Health for All
Statement of NIDDK Director Griffin P. Rodgers, M.D., for World Kidney Day 2015.
MorphoSys and Emergent BioSolutions Initiate Phase 1 Clinical Study
Phase 1 study to evaluate the novel oncology immunotherapeutic MOR209/ES414 for prostate cancer.
NIH-supported Clinical Trials to Evaluate Long-acting, Injectable Antiretroviral Drugs
Both trials are expected to be completed in 2017.
Single-Cell, 42-plexed Protein Analysis Achieved with a New Microchip Technology
A novel microdevice capable of detecting 42 unique immune effector proteins has been developed.
Paramedics May be First Line of Treatment for Stroke
NIH study demonstrates feasibility of getting drugs to stroke patients faster.
Cancer Treatment with KU Origins Enters Second Clinical Trial
Cleave Biosciences has begun a Phase 1 clinical trial to evaluate CB-5083.
Ebola Vaccine Trial Opens in Liberia
Study led by Liberia-NIH partnership will test two experimental vaccines.
NIH Launches Tool to Advance Down Syndrome Research
Web portal will help approved professionals to plan clinical studies.
NIH Researchers Tackle Thorny Side of Gene Therapy
Pre-clinical studies in mice reveal ways to reduce cancer risk with modified treatment.
Scroll Up
Scroll Down

SELECTBIO Market Reports
Go to LabTube
Go to eposters